Avadel Pharmaceuticals PLC (STU:AWK)
€ 10 0.15 (1.52%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.69 GF Score: 42/100

Q3 2024 Avadel Pharmaceuticals PLC Earnings Call Transcript

Nov 12, 2024 / 01:30PM GMT
Release Date Price: €15.1
Operator

(Operator Instructions) Good day, everyone, and welcome to today's Avadel Pharmaceuticals 3Q '24 Earnings Call. (Operator Instructions) Please note, this call is being recorded (Operator Instructions). It is now my pleasure to turn the conference over to Austin Murtagh with Precision AQ.

Austin Murtagh
Precision AQ - IR

Good morning, and thank you for joining us on our conference call to discuss Avadel's Third Quarter 2024 results. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks and uncertainties are described in Avadel's public filings under the Exchange Act included in the Form 10-K for the year ended December 31, 2023, which was filed on February 29, 2024, and subsequent SEC filings.

Except as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot